C-(2-Methyl-2 H -pyrazol-3-yl)-methylamine, 95.0%, 10g

(2-Iodoethyl)benzene (stabilized with Copper chip)>98.0%(GC)5g

2-(3,4-Dihydro-2H-1,5-benzodioxepin-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 1g

acteoside, with analyt. Documents, 20 mg, glass packaging

2-(Trifluoromethyl)phenylacetonitrile, 98.0%, 5g

4-(Tetrahydro-2H-pyran-4-yl)pyridine 1-oxide, 1g

1-ethyl-3-methyl-2-piperazinone hydrobromide, 95.0%, 1g

2-Chloro-6-(trifluoromethoxy)aniline, 25g

Isopropyl disulfide, 95%+, 25g

6-METHOXY-5-NITRO (1H)INDAZOLE, 95%, 25g

2-(Chloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

Fmoc-(R)-3-Amino-4-(2-methyl-phenyl)-butyric acid, 97%, 100mg

1-(6-Methoxy-5-(4-methyl-1H-imidazol-1-yl)pyridin-2-yl)ethan-1-one, 98%, 100mg